LifeStance Health Group, Inc.

NASDAQ:LFST

Medical - Care Facilities

Healthcare
$13.77 +1.99%

+$0.17 today

Market cap
$5.24B
Beta
1.19
P/E (TTM)
146.6
EPS (TTM)
$0.06
52W Low $3.74High $8.89

Volume 6.60M

Average 3.91M

LFST Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

LifeStance Health Group, Inc.NASDAQ: LFST

Stock-Based Compensation · Q2 FY2026 · quarter ended Jun 2026

Stock-based compensation declines year over year

Q2 FY2026 stock-based compensation of $19.75M fell 6.5% year over year, behind the -1.1% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 29.9% from the prior quarter. Over 3 fiscal years it compounded at -26.4% a year.

Context

  • Stock-based compensation amounted to 5.2% of revenue in FY2025, down 0.8 pp from a year earlier.
  • Stock-based compensation increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -6.5% toward the trailing-twelve-month pace of -1.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$19.75M+29.9% QoQ
Last fiscal yearDec 2025
$74.7M-1.9% YoY
LTMJun 2026
$69.95M-1.1% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-6.5%——
1 year-1.9%——
3-year CAGR-26.4%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
74.7M USD
Year-over-year change
-1.9%
4-year CAGR
-26.7%

Stock-Based Compensation vs competitors

How LFST compares with its peers on the latest reported figures

  • LFST's LTM Jun 2026 stock-based compensation of $69.95M is the 2nd largest of the 7 companies compared; the peer median is $41.51M.
  • Its year-over-year change of -1.1% is the 3rd highest of 7, against a peer median of -27.8%.
  • Stock-based compensation amounts to 4.4% of revenue for LFST, versus a peer median of 0.7%.
LFST Competitors Peer median
Stock-Based Compensation for LFST and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HIMSHims & Hers Health, Inc.LTM Sep 2026$177.94M +42.2%+46.7%6.2%
LFSTLifeStance Health Group, Inc.LTM Jun 2026$69.95M -1.1%-26.4%4.4%
BTSGBrightSpring Health Services, Inc. Common StockLTM Sep 2026$55.41M -20.5%+170.4%0.4%
UHSUniversal Health Services, Inc.LTM Jun 2026$48.37M -51.1%+3.9%0.3%
ACHCAcadia Healthcare Company, Inc.LTM Sep 2026$34.64M +37.2%+2.3%1.0%
LFMDLifeMD, Inc.LTM Mar 2026$7.95M -35.1%-8.6%3.6%
PRVAPrivia Health Group, Inc.LTM Jun 2026$0 -100.0%—0.0%
Peer median (excluding LFST) $41.51M-27.8%+3.9%0.7%

Competitors are the stored peer set for LFST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(307.2M)(215.56M)(186.26M)(57.44M)9.66M
Depreciation & Amortization54.14M69.2M80.44M70.95M54.75M
Deferred Income Tax(26.95M)(16.73M)(21.92M)(958K)2.42M
Stock-Based Compensation259.44M187.43M99.39M76.17M74.7M
Change in Working Capital2.14M(16.94M)(33.72M)(27.37M)(40.34M)
Accounts Receivables(24.21M)(21.66M)(24.18M)(6.4M)36.09M
Inventory00000
Accounts Payables623K7.67M(5.61M)501K(1.56M)
Other Working Capital25.73M(2.94M)(3.94M)(21.47M)(74.87M)
Other Non-Cash Items27.85M45.4M45.2M45.91M44.96M
Operating Cash Flow9.42M52.79M(16.88M)107.26M146.15M
Capital Expenditures(94.49M)(79.26M)(40.52M)(21.57M)(36.13M)
Acquisitions (Net)(99.58M)(60.21M)(19.82M)00
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow(194.08M)(139.46M)(60.34M)(21.57M)(36.13M)
Debt Repayment(223.77M)69.56M55.28M(1.69M)(7.25M)
Common Stock Issued549.91M0000
Common Stock Repurchased0(904K)000
Dividends Paid00000
Other Financing Activities(12.28M)(21.39M)(7.86M)(8.26M)(8.71M)
Financing Cash Flow313.86M47.26M47.43M(9.95M)(15.96M)
Effect of Forex Changes00000
Net Change in Cash129.2M(39.41M)(29.8M)75.75M94.07M
Free Cash Flow(85.07M)(26.47M)(57.4M)85.69M110.03M

LifeStance Health Group, Inc.

NASDAQ:LFST

Intrinsic Alpha fair value

Locked

Current Price

$13.77

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.